MHLW Council Recognizes High Medical Need for 4 APIs/5 Products Including Extended-Release Levodopa/Carbidopa Combo

A panel of the Ministry of Health, Labor and Welfare (MHLW) agreed on February 15 that a high unmet medical need exists for four active pharmaceutical ingredients (APIs)/five products including an extended-release levodopa/carbidopa combination product for Parkinson’s disease. The MHLW...read more